Related Experiment Video

Updated: Jun 14, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K

Epigenetic Modifiers in Cancer Metastasis

Die Hu1,2, Tianci Zhao3, Chenxing Xu2

  • 1Key Laboratory of Molecular Genetics between Kangda College of Nanjing Medical University and Suzhou Medical College of Soochow University, Suzhou 215123, China.

Biomolecules
|August 29, 2024
PubMed

Insights

Epigenetic modifications drive cancer metastasis by altering processes like cell migration and invasion. Understanding these epigenetic regulators offers new diagnostic and therapeutic strategies for metastatic cancer.

Area of Science:

  • Oncology
  • Epigenetics
  • Cancer Biology

Background:

  • Metastasis is the leading cause of cancer mortality, involving complex molecular pathways.
  • Epigenetic modifications are increasingly recognized as critical regulators of cancer progression and metastasis.

Purpose of the Study:

  • To comprehensively review recent advances in the role of epigenetic modifiers in cancer metastasis.
  • To elucidate the crosstalk between epigenetic regulators in metastasis-associated processes.
  • To explore the diagnostic, therapeutic, and prognostic potential of epigenetic targets in metastatic cancer.

Main Methods:

  • Literature review of recent research on epigenetics and cancer metastasis.
  • Analysis of key epigenetic mechanisms including histone modifications, DNA methylation, and non-coding RNAs.
  • Examination of enhancer reprogramming, chromatin accessibility, and N6-methyladenosine (m6A) modifications.

Main Results:

  • Epigenetic modifiers significantly influence epithelial-mesenchymal transition (EMT), cancer cell migration, and invasion.
  • Crosstalk between various epigenetic regulators plays a crucial role in promoting tumor metastasis.
  • Specific epigenetic alterations are linked to distinct metastatic behaviors and patient outcomes.

Conclusions:

  • Epigenetic mechanisms are fundamental drivers of cancer metastasis.
  • Targeting epigenetic regulators holds promise for novel diagnostic and therapeutic strategies in metastatic cancers.
  • Further research into epigenetic crosstalk is essential for developing effective anti-metastasis treatments.
Keywords:
DNA methylationepigeneticshistone methylationmetastasisnon-coding RNAs

More Related Videos

Methylated DNA Immunoprecipitation21:24

Methylated DNA Immunoprecipitation

Published on: January 2, 2009

23.3K
Author Spotlight: Epigenetic Modifications and Metabolic Rewiring as Targets for Cancer Therapy07:20

Author Spotlight: Epigenetic Modifications and Metabolic Rewiring as Targets for Cancer Therapy

Published on: October 18, 2024

486

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
8.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K